275 related articles for article (PubMed ID: 10872670)
1. Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: a contribution to the new WHO classification of the urothelial tumors of the urinary bladder.
Helpap B; Köllermann J
Hum Pathol; 2000 Jun; 31(6):745-50. PubMed ID: 10872670
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.
Cina SJ; Lancaster-Weiss KJ; Lecksell K; Epstein JI
Arch Pathol Lab Med; 2001 May; 125(5):646-51. PubMed ID: 11300936
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of atypical papillary urothelial hyperplasia.
Swierczynski SL; Epstein JI
Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
[TBL] [Abstract][Full Text] [Related]
4. [Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions].
Helpap B; Köllermann J
Pathologe; 2000 May; 21(3):211-7. PubMed ID: 10900613
[TBL] [Abstract][Full Text] [Related]
5. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
[TBL] [Abstract][Full Text] [Related]
6. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
Yin H; Leong AS
Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
[TBL] [Abstract][Full Text] [Related]
7. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder.
Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Navone R
Am J Surg Pathol; 2001 Dec; 25(12):1528-33. PubMed ID: 11717543
[TBL] [Abstract][Full Text] [Related]
8. [New WHO classification of urothelial carcinoma of the urinary bladder].
Helpap B
Verh Dtsch Ges Pathol; 2002; 86():57-66. PubMed ID: 12647352
[TBL] [Abstract][Full Text] [Related]
9. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
[TBL] [Abstract][Full Text] [Related]
10. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
[TBL] [Abstract][Full Text] [Related]
11. A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder.
Roperto S; Borzacchiello G; Brun R; Leonardi L; Maiolino P; Martano M; Paciello O; Papparella S; Restucci B; Russo V; Salvatore G; Urraro C; Roperto F
J Comp Pathol; 2010; 142(2-3):95-108. PubMed ID: 19818448
[TBL] [Abstract][Full Text] [Related]
12. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
13. Flat intraepithelial lesions of the urinary bladder.
Cheng L; Cheville JC; Neumann RM; Bostwick DG
Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap.
Nguyen JK; Przybycin CG; McKenney JK; Magi-Galluzzi C
Hum Pathol; 2020 Apr; 98():81-88. PubMed ID: 32142835
[TBL] [Abstract][Full Text] [Related]
15. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
McKenney JK; Amin MB; Young RH
Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056
[TBL] [Abstract][Full Text] [Related]
16. Urothelial papilloma of the bladder: a review of 34 de novo cases.
Magi-Galluzzi C; Epstein JI
Am J Surg Pathol; 2004 Dec; 28(12):1615-20. PubMed ID: 15577681
[TBL] [Abstract][Full Text] [Related]
17. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.
Edgecombe A; Nguyen BN; Djordjevic B; Belanger EC; Mai KT
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):264-71. PubMed ID: 22498670
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
19. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system.
Miyamoto H; Miller JS; Fajardo DA; Lee TK; Netto GJ; Epstein JI
Pathol Int; 2010 Jan; 60(1):1-8. PubMed ID: 20055945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
